Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

New Zealand vaccine producer closer to goal

New Zealand vaccine producer closer to goal by integrating mRNA Covid-19 technology with Australian research partner

COVID-19 Vaccination Corporation (CVC), New Zealand’s most experienced group of vaccine researchers have joined forces with Australia’s BASE Nucleic Acids Biomanufacturing Facility to produce an mRNA COVID-19 vaccine.

To date, CVC has been working on its own unique T-cell COVID-19 vaccine to complement existing vaccines as an enhancer. CVC’s vaccine is designed to work differently to currently marketed COVID-19 vaccines, with the main aim of protecting against COVID’s current and future variants, including the more infectious Delta variant, which has resulted in a strict nationwide level 4 lockdown in New Zealand.

“CVC’s vaccine can do this because it does not rely on generating antibodies, unlike all COVID-19 vaccines being administered at the moment,” says CVC Chief Executive Dr Robert Feldman.

Since launching its vaccine research efforts in 2020, two events have spurred CVC into expanding its programme to include the development of a new mRNA vaccine. Firstly, CVC now has successful pre-clinical results which are significant for progressing its research.

Secondly, the well-documented efficacy of mRNA-based vaccines from Moderna and Pfizer/BioNTech have encouraged researchers, with the promise of this additional approach broadening the applicability of CVC’s technology to multiple delivery platforms.

“CVC’s vaccine is designed to protect not only against existing variants but also ones that may emerge in the future which is a main focus. Our vaccine can be delivered using a variety of methods,” says Dr Feldman.

“Up until now, we have used a polypeptide subunit approach but, excitingly, we are now in a position to use the newer mRNA method. We are particularly pleased to be able to collaborate with BASE to aid us in achieving our new goal,” he adds.

As mRNA vaccines have demonstrated their abilities to be quickly developed, CVC’s collaboration with BASE Nucleic Acids Biomanufacturing facility, part of the Protein Expression Facility at the University of Queensland, will explore how CVC’s T-cell vaccine technology can be rapidly adapted to this emerging technology.

BASE is collaborating with CVC to design T-cell COVID-19 mRNA vaccine candidates. BASE will produce the mRNA vaccine’s active substance which will be supplied to CVC for formulation and evaluation in pre-clinical studies.

“We are pleased to help accelerate CVC’s research effort to adapt its proprietary T-cell vaccine to the mRNA platform technology and diversify the strategy employed to deliver the innovative vaccine,” says Dr Romain Tropée, Nucleic Acids Production Lead at BASE Nucleic Acids Biomanufacturing Facility.

BASE is supported by Therapeutic Innovation Australia and the University of Queensland, offering advanced biomanufacturing of high-quality and high-purity mRNA and DNA products to accelerate and enhance research translation.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 



BusinessNZ: Third Snapshot Report Reveals $9.5 Billion Business Investment In Climate Action

Signatories to the Climate Leaders Coalition have committed to invest $9.5 billion over the next five years to reduce emissions from their businesses, as revealed in their third anniversary snapshot report released today... More>>

Digitl: The home printer market is broken
Printers are more of a security blanket that a serious aid to productivity. Yet for many people they are not optional.
Even if you don’t feel the urge to squirt ink onto dead trees in order to express yourself, others will insist on printed documents... More>>


Serious Fraud Office: Commences Enquiries Into Allegations Of COVID-19 Wage Subsidy Fraud
The Serious Fraud Office has commenced a number of enquiries into alleged abuse of the Government’s COVID-19 Wage Subsidy. Director Julie Read said the allegations relate to multiple complex cases of potential fraud that have been referred to the agency following extensive investigations ... More>>

ComCom: Companies In Hot Water For Selling Unsafe Hot Water Bottles And Toys

A wholesaler and a retailer have been fined a total of $140,000 under the Fair Trading Act for selling hot water bottles and toys that did not comply with mandatory safety requirements. Paramount Merchandise Company Limited (Paramount) was fined $104,000 after pleading guilty in the Manukau District Court... More>>



Reserve Bank: Robust Balance Sheets Yield Faster Economic Recovery

Stronger balance sheets for households, businesses, financial institutions and the government going into the pandemic contributed towards maintaining a sound financial system and yielding a faster economic recovery than following previous deep recessions... More>>


Transpower: Releases Independent Report Into Events Of August 9
Transpower’s Chief Executive Alison Andrew has today released an independent report into the grid emergency of August 9 when insufficient generation was available to meet demand, leading to some customers being disconnected... More>>